Is it a Drug or a Bug? A Case of Chemotherapy and Immune Modulators Complicating the Diagnosis of Ehrlichiosis

Authors

  • Mason E. Uvodich, B.S., MS-3 University of Kansas School of Medicine, Kansas City, KS
  • Victoria Poplin, M.D. University of Kansas School of Medicine, Kansas City, KS, Department of Internal Medicine
  • Heather J. Male, M.D. University of Kansas School of Medicine, Kansas City, KS; Department of Internal Medicine; Division of Hematologic Malignancies and Cellular Therapeutics (HMCT)

DOI:

https://doi.org/10.17161/kjm.v11i3.8695

Keywords:

ehrlichiosis, immunocompromised patient, leukemia, chemotherapy, tick-borne diseases

Metrics

File downloads
335
Jan 2019Jul 2019Jan 2020Jul 2020Jan 2021Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 20269
|

Downloads

Published

2019-01-15

Issue

Vol. 11 No. 3 (2018)

Section

Case Reports

License

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Uvodich, M. E., Poplin, V., & Male, H. J. (2019). Is it a Drug or a Bug? A Case of Chemotherapy and Immune Modulators Complicating the Diagnosis of Ehrlichiosis. Kansas Journal of Medicine, 11(3), 76-77. https://doi.org/10.17161/kjm.v11i3.8695